Roivant Sciences ROIV Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $1.42B+1,411% | $93.95M-48.6% | $182.67M-89.2% | $1.69B-18.4% | ||
| $2.87B+32.3% | $2.17B— | $0— | —— | ||
| $5.17B+3.3% | $5B-25.7% | $6.73B+274% | $1.8B-16.2% | ||
| $11.99M-0.6% | $12.06M-21.3% | $15.32M-60.8% | $39.09M+50.9% | ||
| $5.71B+5.0% | $5.44B-24.7% | $7.22B+202% | $2.39B-7.6% | ||
| $18M-24.0% | $23.69M+68.9% | $14.03M-62.9% | $37.83M+9.4% | ||
| —— | $1.17M-72.0% | $4.17M-66.5% | $12.44M+22.6% | ||
| $281.24M+88.2% | $149.41M-44.0% | $266.76M-2.1% | $272.45M+47.8% | ||
| $416.28M+66.7% | $249.74M-67.7% | $773.95M-1.0% | $782.02M+49.3% | ||
| $0— | $0— | $0— | $0— | ||
| -$501.81M-532% | $116.06M-79.9% | $576.17M+115% | -$3.77B-36.5% | ||
| $4.53B-3.4% | $4.69B-21.5% | $5.97B+416% | $1.16B-30.1% | ||
| $5.71B+5.0% | $5.44B-24.7% | $7.22B+202% | $2.39B-7.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Roivant Sciences's total assets?
- Roivant Sciences (ROIV) holds $5.7B in total assets, up 5.0% year over year.
- How much debt does Roivant Sciences have?
- Roivant Sciences carries $107.4M in total debt against $4.5B of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Roivant Sciences have?
- Roivant Sciences holds $1.4B in cash and equivalents.
- Can Roivant Sciences cover its short-term obligations?
- Its current ratio is 18.37 — current assets exceed current liabilities.
- Where does Roivant Sciences's balance sheet data come from?
- Every line is extracted from Roivant Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
